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Increasing Actual and Perceived Burden of Tick-Borne 
Disease in Maine
Robert P. Smith MD, MPH,1 Carol A. McCarthy MD2, Susan P. Elias PhD1
1Vector-borne Disease Research Laboratory, Maine Medical Center Research Institute, Scarborough, ME, 2Department of 
Pediatrics, Maine Medical Center, Portland, ME
Introduction:  The burden of tick-borne diseases (TBDs) in Maine has steadily increased since the first case of 
Lyme disease was reported in the late 1980s. Five different agents of TBDs have emerged in Maine, 
challenging clinicians and the public .
Methods:  We reviewed the ecology of emerging TBDs as well as the risk factors for tick bites and TBDs in Maine. 
We then evaluated the burden of TBDs versus comparable community-acquired infections in terms of 
hospitalizations, deaths, and media attention.
Results:  In Maine, the risk of exposure to bites from the vector blacklegged or “deer tick”, Ixodes scapularis, is a 
reality in most of the state. In New England, the deer tick’s range has expanded from relict populations 
in southern New England northward due to reforestation, resurgence of white-tailed deer (Odocoileus 
virginianus), suburbanization, and climate change. In Maine, TBDs have emerged as a significant 
health burden, but they receive disproportionately high media attention compared with other infections 
important to public health. Measures of TBD severity provide a necessary context for individual and 
public health decision-making. Mass media reports and social networking inform much public debate 
regarding TBDs, but in many instances, they do not accurately reflect their actual prevalence or expected 
outcome.
Conclusions:  Reducing actual and perceived risks associated with TBDs will require well-supported information and 
an appreciation for how interpersonal communication and social media drive community perceptions 
and responses to the emergence of TBDs. 
Keywords:  deer tick, Lyme disease, Ixodes scapularis, tick-borne disease
Since the first reports of Lyme disease in Maine in 1986, tick-borne diseases (TBDs) have assumed an increasingly high  profile 
in the state’s public health reports1 and in public 
attention. The deer (blacklegged) tick (Ixodes 
scapularis), now widespread across Maine, carries 
up to five different  human pathogens. The recent 
emergence of this tick and the diseases it can 
transmit  represent a remarkable occurrence in the 
regional annals of infectious diseases.2
Case reports of Lyme disease rose from a few per 
year in the late 1980s to more than a thousand per 
year during the past five years. These reports are 
likely a significant underestimate of actual cases. 
Geographic risk increased from a few southern and 
coastal counties to nearly all areas of the state.1,3 
Anaplasmosis and babesiosis cause serious 
infection in the elderly or immune suppressed,4 and 
cases of both infections increased sharply from 2013 
to 2017 [605% (94 to 663) for anaplasmosis and 
69% (36 to 118) for babesiosis].1 These ticks also 
can transmit a virus (Powassan virus or “deer-tick 
virus”) that can cause a devastating encephalitis, an 
effect underscored by the death of a Maine resident 
from this agent in 2013.5 To add to the complexity, 
another species of Borrelia (B. miyamotoi), which 
differs in some aspects from B. burgdorferi, causes 
a febrile illness similar to anaplasmosis. If untreated, 
it can occasionally cause relapses of fever.6 The full 
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spectrum of disease caused by Powassan virus 
and Borrelia miyamotoi is still under study.
This article first reviews what we know about the 
ecology of emerging of TBDs. Then it reviews risk 
factors for tick bites and TBD in Maine. We discuss 
this phenomenon in the broader context of public-
health threats in Maine through data we gathered 
on hospitalizations and deaths attributable to TBDs, 
which we compared to conditions such as influenza. 
We also assessed the volume of news coverage 
of TBDs versus comparison conditions. In doing 
so, we revealed a disconnect between standard 
measures of the burden of TBD versus the burden 
implied by the frequency of media coverage. We 
also addressed causes and consequences of 
public misperceptions of disease prevalence and 
outcome.
Review: Ecology of emerging TBD in Maine
Progressive expansion of deer ticks across the 
northeastern United States and the upper Midwest 
reflects widespread ecologic changes.7,8 The rising 
incidence of human TBD is due to the geographic 
range expansion of deer ticks and increased 
human encounters with ticks in residential areas.3,8,9 
However, enhanced clinical recognition and 
availability of improved diagnostic tests may also 
contribute to the increase in case reports.
In the late 1980s, deer ticks appeared in Maine in 
a discontinuous distribution that included sites in 
southern coastal York and Cumberland Counties, 
as well as Acadia National Park and remote islands, 
such as Monhegan Island.3,10,11,12 This patchy pattern 
of initial colonization of Maine by Ixodes scapularis 
is best explained by passerine birds that introduce 
the tick while they migrate during the spring, as 
shown by studies on migrating birds banded on 
Appledore Island.13 Once dispersed by birds, larval 
and nymphal ticks feed upon small rodents, and to 
a lesser extent, larger mammals and birds. Adult 
ticks feed on large mammal hosts, particularly 
white-tailed deer. White-tailed deer are the key 
large mammal involved in the tick’s life cycle, as a 
large number of ticks feed and mate on them.14 
Why the relatively recent dispersal of deer ticks by 
migrating birds? The most compelling explanation 
is the increase in white-tailed deer abundance in 
the northeast United States. Deer ticks were once 
isolated to relict populations in southern New 
England. They have expanded geographically 
during the 20th and 21st century, due to resurgence 
of white-tailed deer populations, reforestation, and 
suburbanization of the landscape.7,15 Abundant 
deer support focal concentrations of deer ticks as 
they are dispersed by migratory birds from endemic 
areas to new ones. 
In the early 1900s, deer populations were sparse 
in much of Maine, gradually increasing over the 
following decades. Through the late-1980s and 
1990s, Maine’s deer population increased 65%, 
rising from ~200,000 deer in 1990 to a high of 
331,000 in 1999.16 This occurred mainly in the 
central and southern tiers of the state, increasing 
the odds that tick populations would establish in 
regions where most of the human population lives. 
Tick abundance is correlated with measures of 
deer abundance in Maine.17 Removal of deer from 
Monhegan Island with subsequent disruption of the 
deer tick life cycle there provided a proof of principle 
of the white-tailed deer’s critical role.17,18
In addition to an increased number of deer, a 
warming climate confers survival advantages to deer 
ticks in northern areas of Maine and adjacent areas 
of Canada.19,20 Climate change is also facilitating 
the movement of other tick vectors northward, with 
reports of Ambylomma americanum, the lone star 
tick, now established in areas of southern New 
England.
Review: Risk factors for deer-tick bites and TBD 
in Maine
In the northeastern US, exposure to deer-tick bites 
occurs primarily in the peri-domestic environment 
(i.e., yards and other areas around residences).9 
This exposure is a product of the time spent in 
activities outside on home properties, and the 
presence of suitable habitat and tick hosts, such 
as rodents and deer, next to households.9,15,21 In 
Maine, Lyme disease incidence varies from lower 
in the northern tier to higher in the southern tier of 
the state (Table 1) likely due to variations in suitable 
climate, bloodmeal-host communities, and habitats.
In addition to the peri-domestic environment, human 
risk of infection varies with outdoor recreational or 
work activities.9 Though early studies demonstrated 
focal risk in the southern and mid-coast counties, 
exposure to deer ticks now occurs  in all areas 
of Maine, with the exception of higher montane 
elevations.3, Within counties, there are areas of high 
risk and areas of low or negligible risk. In open fields 
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and drier habitats, bites by other tick species, such 
as dog ticks (Dermacentor variabilis) that do not 
carry diseases in Maine, are more likely. Of 12 tick 
species removed from humans in Maine, dog ticks 
are the second-most common human-biting tick 
after deer ticks.3 Habitat studies have shown deer 
ticks are less associated with fields and softwood 
(coniferous) forests and more associated with 
hardwood and mixed hardwood/softwood forests. 
They are especially associated with dense thickets 
of invasive plants, such as Japanese barberry or 
American bittersweet.22 Higher rates of tick contact 
near homes also occur at lawn edges bordered by 
brush or forest.21
Reported cases of Lyme disease in Maine have 
a bimodal age distribution, indicating highest risk 
in youth (ages 5 to 14) and adults over age 45.1 
However, susceptibility to clinical illness from Lyme 
disease does not vary with age, whereas diseases 
such as anaplasmosis and babesiosis occur more 
often and with greater severity with older age. Illness 
due to anaplasmosis or babesiosis is uncommon in 
the pediatric population.1 While Lyme disease and 
anaplasmosis may be acquired by deer tick bites 
anywhere the tick occurs in Maine, babesiosis risk 
is more geographically limited, with human cases 
largely confined to areas with the highest risk of 
Lyme disease.4 Asplenia, immune compromise, 
and age are risk factors for severe babesiosis.23 
Rarer agents of disease, such as B. miyamotoi and 
Powassan virus, only infect a few percent of Maine 
ticks but are present in deer ticks in most locations 
studied (Maine Medical Center Research Institute 
Vector Borne Disease Laboratory; unpublished 
data).
The ubiquitous presence of ticks in many peri-
domestic environments results in a high frequency 
of tick encounters and bites in the community, 
heightening concerns about the risk of illness.9,15 
Syndromic surveillance in Maine, based on 
documentation of visits to Maine urgent care 
centers and ERs,24 show peaks of over 100 “tick 
encounters” per day during peak weeks in early 
summer (nymphs) and mid-fall (adults). The 
Centers for Disease Control (CDC) reported that 
in suburban residences of southern New England, 
nearly 10% of individuals studied reported peri-
domestic tick contact during one summer week 
of high tick activity.9 Similar numbers may apply 
to higher risk residential areas in Maine. The high 
frequency of tick encounters leads to appropriate 
public concerns regarding the consequences of 
tick bites. However, subjective perceptions of the 
inherent risk of infection from a deer tick bite are 
often overestimated, as are the expected negative 
health consequences of TBDs.25–27
If a deer tick bite occurs, the objective risk of 
illness varies with the infectious agent, the time of 
tick attachment, subject age, immune status, and 
geography.15 Well-designed studies demonstrate 
that transmission of Lyme disease usually requires 
continuous tick attachment for more than 36–48 
hours.28,29 As many ticks are removed early in 
their feeding, the objective risk of acquiring Lyme 
disease after removing an attached deer tick within 
72 hours is less than 5%, even though up to 50% of 
nymphal deer ticks carry B. burgdorferi.15,28–30 Adult 
ticks are discovered and removed prior to 36 hours 
of attachment (64%) more often than the much 
smaller nymphs (40%).15,31 Data are less robust for 
other agents. However, most disease transmission 
requires 24 hours of attachment, with the significant 
exception that Powassan virus may be transmitted 
in only 15 minutes of tick attachment.30 Ticks 
Table 1. Five-year average incidence (cases per 
100,000) of the three most common tick-borne diseases 
vectored by Ixodes scapularis in Maine (2013–2017)*.
State/County Anaplasmosis Babesiosis Lyme disease
Maine 22.6 5.0 110.5
Androscoggin 14.3 2.8 75.8
Aroostook 0.6 0.0 5.5
Cumberland 17.0 4.6 109.0
Franklin 3.3 0.0 38.5
Hancock 17.6 1.5 256.0
Kennebec 20.2 3.3 156.0
Knox 138.0 31.7 287.6
Lincoln 133.0 17.0 236.1
Oxford 9.8 2.4 76.9
Penobscot 1.4 0.9 46.4
Piscataquis 2.4 1.2 15.3
Sagadahoc 67.1 11.4 184.3
Somerset 3.1 1.6 75.1
Waldo 29.6 1.5 211.4
Washington 1.3 0.0 63.1
York 27.5 9.2 105.3
*There have been six cases of hard-tick relapsing fever 
caused by Borrelia miyamotoi: 2016-2, 2017-6;  and six 
cases of Powassan encephalitis: 2013-1, 2015-1, 2016-
1, 2017-31
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feeding to repletion over a longer interval steadily 
increases the risk of disease transmission.28 Most 
cases of Lyme disease occur without a reported 
tick bite, indicating that the infecting tick is often not 
found before it finishes feeding.15 While co-infection 
of deer ticks with more than one pathogen has been 
documented in 0–5% of Maine ticks (depending on 
the location; unpublished data), the vast majority 
of reported cases of TBD are due to infection by a 
single agent.
Actual and perceived burden of TBD in Maine
Hospitalization data were obtained from the 
Maine Health Data Organization using ICD9 and 
ICD10 codes. For the chronic conditions hepatitis 
B, hepatitis C, and HIV, hospitalizations were 
counted on the basis of primary diagnosis. For the 
acute TBDs and influenza, hospitalizations were 
counted on the basis of either primary diagnosis 
or other diagnosis 1 through 8. For endocarditis 
with drug use, we counted hospitalizations 
using the codes described by Fleischauer et al.32 
Sources for mortality data included TBD deaths 
in Maine residents (Robinson S, M.P.H., personal 
communication, January 8, 2019) and Maine 
Resident Deaths33 for non-vector-borne deaths. 
Deaths from endocarditis with drug use were not 
available from Maine Resident Deaths, so these 
deaths were estimated as 19% of hospitalizations 
(Table 2) based on recent findings.34 Finally, we 
conducted a Lexis Uni® database search of media 
coverage, specifying coverage between January 1, 
2014 and December 31, 2018, the word “Maine”, 
and the infectious disease conditions described in 
Table 2.
There were fewer hospitalizations (23.3%) 
and deaths (0.2%) attributable to TBDs than 
hospitalizations (76.7%) and deaths (99.8%) due to 
the other infections examined (Table 2). In contrast, 
the Lexis Uni® database search of media coverage 
revealed that 41.4% of news coverage focused on 
Lyme disease and other TBDs compared to 58.6% 
for the other infectious diseases that threaten public 
health.
Combined hospital admissions for TBDs may rival 
some other individual reportable infections (Table 
2), but with far fewer fatalities. Fatalities from Lyme 
disease have been reported in a small number of 
patients with Lyme carditis nationwide.35 These 
fatalities are exceedingly rare36 and are quite 
infrequent with anaplasmosis or babesiosis, despite 
potentially severe disease in the elderly and immune 
suppressed.23 Other community-acquired infections 
leading to hospitalization more significantly burden 
public health when measured by mortality (Table 2). 
Notably, the collateral effects of infections related to 
the opioid epidemic (i.e., infections associated with 
use of injected drugs, including hepatitis C, bacterial 
endocarditis, and osteomyelitis) have rapidly risen 
in prevalence.
Table 2. Frequency of hospitalizations for and deaths from tick-borne diseases and select non-vector-borne 
diseases or conditions (2013–2017), and frequency of news articles that mentioned Maine and the selected 
diseases or conditions (January 1, 2014–December 31, 2018).
Hospitalizations Deaths News Articles
Disease or Condition Count % of Total Count % of Total Count % of Total
Tick-borne
Anaplasmosis 419 12.3 2 0.1 47 2.9
Babesiosis 116 3.4 3 0.1 34 2.1
Borrelia miyamoti disease unknown 0 0.0 6 0.4
Lyme disease* 261 7.6 0 0.0 555 34.0
Powassan unknown 1 0.0 33 2.0
Total tick-borne 796 23.3 6 0.2 675 41.4
Non-vector-borne
Hepatitis B,C 344 10.1 223 7.6 174 10.7
HIVe 278 8.1 96 3.3 481 29.5
Influenza 1998 58.5 2599 88.9 299 18.3
Endocarditis with drug use 593 17.4 113 3.9 1 0.1
Total Non-vector-borne 2620 76.7 2918 99.8 954 58.5
Total 3416 2924 1629
*Lyme hospitalizations included 227 of Lyme, Lyme arthritis, and Lyme meningitis, plus 34 of Lyme carditis
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Repetitive coverage of any particular infectious 
disease by the mass media heightens the public’s 
perceptions of disease risk and severity.25 This effect 
can stimulate further media attention in an amplified 
cycle that increases the public’s perceptions of risk 
even more.37 In addition, the content of mass media 
reports on Lyme disease often highlights individual 
narratives of unusually long or debilitating illness 
attributed to chronic infection.25 These reports are 
frequently re-enforced by interpersonal information 
from social networks.26 A survey of residents in two 
endemic sites in southern New England noted that 
inaccurate views of the expected clinical outcomes 
of Lyme disease were based upon shared 
personal narratives rather than information from 
physicians, the CDC, or state health departments.26 
Anecdotal reports amplified by social media may 
result in “information silos” that  not only increase 
the prevalence of unchallenged misinformation, 
but also appear to fuel distrust of information 
provided by public health and medical experts.38-41 
Nationally, prevalence of public misconceptions 
regarding current scientific evidence contributes to 
incomplete use of proven preventive measures.27,40 
They also contribute to overuse of antibiotic and 
unproven treatment strategies, including long-term 
polypharmacy for putative multiple co-infections.42-46
The emergence of TBDs in Maine over the past 
3 decades represents a substantial challenge in 
public health. Yet the concomitant perpetuation 
of disparate beliefs regarding the risks of TBDs 
complicates both individual decisions regarding 
treatment and the public health response.26, 38-40,44-47 
There are no published Maine-based surveys that 
document the current prevalence and the range 
of knowledge and beliefs regarding the risks and 
consequences of TBDs. However, the public’s 
high concern is reflected by advocacy for Maine 
legislative initiatives (i.e., three bills specific to Lyme 
disease signed between 2013 and 2018), media 
attention (Table 2), and Maine CDC investment in 
public educational initiatives as outlined in annual 
reports to the Maine Legislature.24
A limitation to our analysis was an inability to assess 
chronic disability. With low mortality rates from TBDs, 
specific measures, such as years of life lost (YLL), 
will also be relatively low. The years of “healthy life 
lost”, or disability-adjusted life years (DALYS), is a 
more challenging measurement.48 Comprehensive 
YLL and DALYS data for TBDs are not available. 
Although long-term prospective outcome studies of 
Lyme disease do not demonstrate differences from 
the health of the general population,49,50 individuals 
may experience persisting complications. For 
example, a small subset of patients treated 
for Lyme arthritis develop a disabling form of 
autoimmune mono-articular joint inflammation. 
Neurologic disease (primarily 7th nerve palsy and/
or Lyme meningitis) was reported in up to 10% of 
newly diagnosed cases of Lyme disease1 and is 
generally slow to resolve after antibiotic treatment. 
Long-term residual neurologic symptoms are 
rarely reported. Continuing controversy regarding 
disease outcomes centers on estimates of the 
incidence and duration of subjective illness 
(e.g., fatigue, arthralgias, cognitive symptoms) 
following antibiotic treatment of documented Lyme 
disease.44,51,52 Similar controversies now extend to 
the full spectrum of possible “co-infecting” TBDs 
and, surprisingly, even to a group of infectious 
agents not demonstrated to be transmitted by deer 
ticks (e.g., Bartonella species).42
The causes of prevalent misconceptions and 
controversies regarding TBDs are manifold. These 
causes are likely related, in part, to the recent 
emergence of these diseases, the variety of their 
clinical manifestations, and the near ubiquitous 
presence of ticks throughout suburban communities 
in the northeastern United States.9,39 Both mass-
media reporting and social networking contribute 
to disparate information on these diseases. The 
degree to which this leads to use of unproven 
treatment strategies deserves study.43,45,46 Further 
studies would assess the volume of social media, 
content of news and social media, and the use of 
unorthodox treatments for TBDs.
CONCLUSIONS
Lessening both the actual risk and perceived risks 
associated with tick-borne infections represents an 
ongoing challenge that needs continued attention 
and effort. As the risk of acquiring TBDs varies 
regionally, continued epidemiologic research 
directed toward Maine communities may provide the 
most accurate data on which to base local initiatives 
for disease prevention. The recognition of new 
TBDs and the changing landscape of disease risks 
with ecological and human dynamics highlight the 
importance of continuing the scientific and clinical 
study of these different agents.2,6 Well-supported 
information on the risks and consequences of 
TBD, and their most effective clinical management, 
optimally informs wise decisions in clinical and 
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public health.26 Continued work to enhance disease 
prevention may include efforts directed at different 
scales, from individuals to regional or community 
approaches. For example, new strategies for 
integrated tick management may lower risk in 
residential areas. Also, vaccine trials currently 
underway may lead to new options for individual 
protection. To impact the burden of TBDs, however, 
these efforts must consider the role of interpersonal 
communication and of social and mass media in 
driving community perceptions and responses to the 
emergence of TBDs.26,47 Realization of the benefits 
of these scientific advances will require effective 
strategies for public and professional education that 
are based upon peer-reviewed scientific evidence.
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